To evaluate the effect of enteral immunonutrients in critically ill patients.
extracted. The mean (with standard deviation, SD) length of hospital stay and mean (SD) duration of mechanical ventilation were also extracted for the intervention and control groups. Risk ratios (relative risk, RR) were calculated for all the outcome variables except length of stay, for which an effect size (ES) was calculated.
Methods of synthesis
How were the studies combined? The authors used maximum likelihood methods of combining RRs across the included studies. The studies were pooled using a random-effects model to estimate the overall RR. The Mantel-Haenszel method was used to test the significance of the treatment effect.
How were differences between studies investigated?
Statistical tests were carried out to investigate heterogeneity (method not stated). Pre-specified subgroup analyses were carried out based on study quality, arginine content and patient group.
Results of the review
Twenty-two RCTs (n=2,419) were included.
Mortality was not reduced by enteral immunonutrition compared with standard formulas (22 studies; RR 1.10, 95% confidence interval, CI: 0.93, 1.31). Although the statistical test for heterogeneity was non significant (p=0.54), the authors stated that a visual inspection suggested heterogeneous treatment effects. A subgroup analysis showed no difference in mortality for high arginine content formulas compared with standard formulas (RR 1.05, 95% CI: 0.88, 1.25), but studies using formulas other than high arginine formula were associated with higher mortality (RR 2.13, 95% CI: 1.08, 4.21), (p=0.06 for the between-subgroup comparison). Mortality was not reduced by immunonutrition in both the critically ill (RR 1.18, 95% CI: 0.88, 1.58) and elective surgical (RR 0.99, 95% CI: 0.42, 2.34) patient groups (p=0.70 for the between-subgroup comparison). The higher quality studies (a score of 8 or more points) showed a trend towards higher mortality (RR 1.19, 95% CI: 0.99, 1.43) for immunonutrition compared with standard formula, whereas the lower quality studies showed a trend towards lower mortality (RR 0.74, 95% CI: 0.49, 1.14), (p=0.06 for the between-subgroup comparison).
In comparison with standard formulas, immunonutrition was associated with fewer patients with infectious complications (18 studies; RR 0.66, 95% CI: 0.54, 0.80). There was statistically-significant heterogeneity (p<0.001). A subgroup analysis showed there was a lower rate of infectious complications in studies with high arginine content formula compared with standard formula (RR 0.55, 95% CI: 0.46, 0.67), but not for the studies using other formulas (RR 1.27, 95% CI: 0.74, 2.22), (p=0.01 for the between-subgroup comparison). Immunonutrition had no effect on the rate of infectious complications in studies of critically ill patients (RR 0.96, 95% CI: 0.77, 1.20) , but was associated with a lower rate of complications in studies of elective surgical patients (RR 0.53, 95% CI: 0.42, 0.68), (p=0.002 for the between-subgroup comparison). The higher quality studies showed a lower rate of infectious complications (RR 0.53, 95% CI: 0.42, 0.68) for immunonutrition compared with standard formula, whereas there was no difference for the lower quality studies (RR 1.01, 95% CI: 0.68, 1.50), (p=0.01 for the between-subgroup comparison).
Compared with standard formulas, immunonutrition was associated with a shorter hospital stay (17 studies; effect size, ES -0.63, 95% CI: -0.94, -0.32). There was statistically-significant heterogeneity (p<0.001). A subgroup analysis showed that the high arginine content formula was associated with a shorter hospital stay (ES -0.77, 95% CI: -1.09, -0.45) whereas the other formulas were associated with longer hospital stays in comparison with standard formulas (ES 0.37, 95% CI: -0.09, 0.83), (p=0.008 for the between-subgroup comparison). Immunonutrition was associated with a shorter hospital stay in both critically ill (ES -0.47, 95% CI: -0.93, -0.01) and elective surgical patients (ES -0.76, 95% CI: -1.14, -0.37), (p=0.95 for the between-subgroup comparison). The higher quality studies showed that immunonutrition was associated with shorter hospital stays in (ES -0.67, 95% CI: -1.00, -0.35), whereas the lower quality studies showed no effect on length of hospital stay (ES -0.37, 95% CI: -1.56, 0.82), (p=0.30 for the betweensubgroup comparison).
Further subgroup analyses in relation to the critically ill patient group only were also reported.
